Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Jimenez-Cortegana, C; Palazon-Carrion, N; Garcia-Sancho, AM; Nogales-Fernandez, E; Carnicero-Gonzalez, F; Rios-Herranz, E; de la Cruz-Vicente, F; Rodriguez-Garcia, G; Fernandez-Alvarez, R; Dominguez, AR; Casanova-Espinosa, M; Martinez-Banaclocha, N; Guma-Padro, J;...

Impact of weight loss on cancer patients’ quality of life at the beginning of the chemotherapy

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Sanz, EA; Abiles, J; Siles, MG; Ruiz, EP; Garcia, JA; Dominguez, AR – 2021

Risk Prediction Tools Available for Germline BRCA1/2 Mutations Underperform in Prostate Cancer Patients

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Oliva, L; Lozano, R; Llacer, C; Aragon, I; Pajares, BI; Saez, MI; Herrera-Imbroda, B; Montesa, A; Hernandez, D; Villatoro, R; Otero, A; Correa, R; Grau, G; Peinado, P; Pacheco, MI; Garcia-Galisteo, E; Rueda, A; Machuca, FJ; Alba, E; Marquez-Aragones, A; Olmos, D;...

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Sierra-Rodero, B; Cruz-Bermudez, A; Nadal, E; Garitaonaindia, Y; Insa, A; Mosquera, J; Casal-Rubio, J; Domine, M; Majem, M; Rodriguez-Abreu, D; Martinez-Marti, A; Carpeno, JD; Cobo, M; Vivanco, GL; Del Barco, E; Caro, RB; Vinolas, N; Aranda, IB; Viteri, S; Massuti, B;...

Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Martin-Bravo, C; Quiros, R; Blancas, I; Villatoro-Roldan, R; Robles, M; Alcaide, J; Navarro, V; Perez, D; Zarcos, I; Rivas-Ruiz, F; Perez-Ruiz, E; Quero, C – 2021

Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage- SCLC: Results From the Phase 3 MERU Study

por prodriguez | Ene 1, 2021 | Publicaciones - CIMO-02

Johnson, ML; Zvirbule, Z; Laktionov, K; Helland, A; Cho, BC; Gutierrez, V; Colinet, B; Lena, H; Wolf, M; Gottfried, M; Okamoto, I; van der Leest, C; Rich, P; Hung, JY; Appenzeller, C; Sun, ZW; Maag, D; Luo, Y; Nickner, C; Vajikova, A; Komarnitsky, P; Bar, J –...